Biomarkers and coptis chinensis activity for rituximab-resistant diffuse large B-cell lymphoma: Combination of bioinformatics analysis, network pharmacology and molecular docking
CONCLUSION: This study revealed biomarkers and Coptis chinensis-associated molecular functions for rituximab-resistant DLBCL.PMID:38517810 | DOI:10.3233/THC-230738
Source: Technology and Health Care - Category: Medical Devices Authors: Qiuling Zhao Shengqiang Huang Lin Yang Ting Chen Xiuliang Qiu Ruyi Huang Liangliang Dong Wenbin Liu Source Type: research
More News: China Health | Databases & Libraries | Drugs & Pharmacology | Genetics | Health Management | Lymphoma | Medical Devices | Rituxan | Study | Switzerland Health